O35433 (TRPV1_RAT) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 100.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Transient receptor potential cation channel subfamily V member 1 Short name=TrpV1 Alternative name(s): Capsaicin receptor Osm-9-like TRP channel 1 Short name=OTRPC1 Vanilloid receptor 1 Vanilloid receptor type 1-like | ||||
| Gene names |
| ||||
| Organism | Rattus norvegicus (Rat) | ||||
| Taxonomic identifier | 10116 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Rattus |
Protein attributes
| Sequence length | 838 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. May be involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Activation by vanilloids, like capsaicin, and temperatures higher than 42 degrees Celsius, exhibits a time- and Ca2+-dependent outward rectification, followed by a long-lasting refractory state. Mild extracellular acidic pH (6.5) potentiates channel activation by noxious heat and vanilloids, whereas acidic conditions (pH <6) directly activate the channel. Can be activated by endogenous compounds, including 12-hydroperoxytetraenoic acid and bradykinin. Acts as ionotropic endocannabinoid receptor with central neuromodulatory effects. Triggers a form of long-term depression (TRPV1-LTD) mediated by the endocannabinoid anandamine in the hippocampus and nucleus accubens by affecting AMPA receptors endocytosis. Ref.1 Ref.2 Ref.6 Ref.8 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.17 Ref.19 Ref.24 |
| Enzyme regulation | Channel activity is activated via the interaction with PIRT and phosphatidylinositol-4,5-bisphosphate (PIP2). Both PIRT and PIP2 are required to activate channel activity By similarity. |
| Subunit structure | Interacts with PIRT By similarity. Self-associates. Probably homotetramer. May also form a heteromeric channel with TRPV3. Interacts with calmodulin, PRKCM and CSK. Interacts with PRKCG and NTRK1, probably by forming a trimeric complex. Ref.8 Ref.12 Ref.15 Ref.20 Ref.21 |
| Subcellular location | Cell junction › synapse › postsynaptic cell membrane; Multi-pass membrane protein. Cell projection › dendritic spine membrane; Multi-pass membrane protein. Note: Mostly, but not exclusively expressed in post-synaptic dendritic spines. Ref.7 Ref.22 |
| Tissue specificity | Predominantly expressed in trigeminal and dorsal root sensory ganglia. Expressed also in hippocampus, cortex, cerebellum, olfactory bulb, mesencephalon and hindbrain. High expression in the cell bodies and dendrites of neurons in the hippocampus and in the cortex. In the brain detected also in astrocytes and pericytes. Isoform 1 and isoform 3 are expressed in brain and peripheral blood mononuclear cells. Ref.1 Ref.2 Ref.22 |
| Domain | The association domain (AD) is necessary for self-association. Ref.23 |
| Post-translational modification | Phosphorylation by PKA reverses capsaicin-induced dephosphorylation at multiple sites, probably including Ser-116 as a major phosphorylation site. Phoshphorylation by CAMKII seems to regulate binding to vanilloids. Phosphorylated and modulated by PRKCE, PRKCM and probably PRKCZ. Dephosphorylation by calcineurin seems to lead to receptor desensitization and phosphorylation by CAMKII recovers activity. Ref.9 Ref.11 Ref.17 Ref.20 |
| Miscellaneous | Responses evoked by capsaicin, but not by low pH and heat, can be antagonized by capsazepine. |
| Sequence similarities | Belongs to the transient receptor (TC 1.A.4) family. TrpV subfamily. TRPV1 sub-subfamily. [View classification] Contains 6 ANK repeats. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O35433-1) Also known as: VR1L1; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O35433-2) Also known as: VR1L2; The sequence of this isoform differs from the canonical sequence as follows: 348-407: Missing. | ||||||
| Isoform 3 (identifier: O35433-3) Also known as: VR.5'sv; The sequence of this isoform differs from the canonical sequence as follows: 1-307: Missing. 348-407: Missing. | ||||||
| Note: Inactive. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 838 | 838 | Transient receptor potential cation channel subfamily V member 1 | PRO_0000215341 | |||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 1 – 432 | 432 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 433 – 453 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 454 – 476 | 23 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 477 – 497 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 498 – 510 | 13 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 511 – 531 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 532 – 535 | 4 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 536 – 556 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 557 – 579 | 23 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 580 – 600 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Intramembrane | 611 – 646 | 36 | Pore-forming; Probable | ||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 659 – 679 | 21 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 680 – 838 | 159 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 110 – 152 | 43 | ANK 1 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 153 – 199 | 47 | ANK 2 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 200 – 246 | 47 | ANK 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 247 – 282 | 36 | ANK 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 283 – 331 | 49 | ANK 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Repeat | 332 – 358 | 27 | ANK 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Region | 684 – 712 | 29 | AD | ||||||||||||||||||||||||||||||||||||||||||||||
| Region | 767 – 801 | 35 | Interaction with calmodulin | ||||||||||||||||||||||||||||||||||||||||||||||
| Region | 777 – 792 | 16 | Required for PIP2-mediated channel inhibition | ||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 116 | 1 | Phosphoserine; by PKA and PKD Ref.11 Ref.20 | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 144 | 1 | Phosphothreonine; by PKA; in vitro Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 370 | 1 | Phosphothreonine; by PKA; in vitro Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 502 | 1 | Phosphoserine; by PKC/PRKCE Ref.9 Ref.11 Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 704 | 1 | Phosphothreonine Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 774 | 1 | Phosphoserine; by PKA; in vitro Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 800 | 1 | Phosphoserine; by PKC/PRKCE and PKC/PRKCZ Ref.9 | ||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 820 | 1 | Phosphoserine; by PKA; in vitro Ref.11 | ||||||||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 604 | 1 | N-linked (GlcNAc...) Ref.7 | ||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 307 | 307 | Missing in isoform 3. | VSP_013431 | |||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 348 – 407 | 60 | Missing in isoform 2 and isoform 3. | VSP_013432 | |||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 114 | 1 | R → E: Abolishes capsaicin-evoked current and binding to resiniferatoxin. Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 114 | 1 | Missing: Abolishes sensitivity to acid. Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 115 | 1 | R → D: Abolishes capsaicin-evoked current and binding to resiniferatoxin. Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 116 | 1 | S → A: Abolishes phosphorylation by PKCM and enhances channel response to capsaicin by PKCM. Ref.20 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 502 | 1 | S → A: Largely reduces PMA enhancement of capsaicin-evoked currents, but no effect on direct activation by PMA. Loss of activation by capsaicin and loss of vanilloid binding; when associated with I-704. Ref.9 Ref.13 Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 511 | 1 | Y → A: Loss of sensitivity to capsaicin. Ref.18 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 547 | 1 | M → L: Reduces binding to resiniferatoxin. Ref.18 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 550 | 1 | T → I: Reduces sensitivity to capsaicin 10-fold; no effect on sensitivity to resiniferatoxin. Reduces binding to resiniferatoxin. Ref.18 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 636 | 1 | E → K: Abolishes channel activity. Restored channel activity; when associated with E-639. Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 636 | 1 | E → Q: Slight modification of pore attributes. Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 639 | 1 | K → E: Restored channel activity; when associated with K-636. Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 644 | 1 | M → Y: Slightly modifies channel permeability. Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 646 | 1 | D → N: Strongly reduces the affinity for pore blocker ruthenium red and lowered channel permeability for Mg(2+). Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 648 | 1 | E → Q: Minor modification of pore attributes. Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 651 | 1 | E → Q: Minor modification of pore attributes. Ref.5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 704 | 1 | T → A: No effect on PMA-induced enhancement of capsaicin-evoked currents but reduces direct activation by PMA. Ref.13 Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 704 | 1 | T → I: Loss of activation by capsaicin and loss of vanilloid binding; when associated with A-502. Ref.13 Ref.17 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 761 | 1 | E → K or Q: Abolishes capsaiin-evoked current and binding to resiniferatoxin. Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 761 | 1 | Missing: Abolishes sensitivity to acid. Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 785 | 1 | R → Q: Abolishes PLC-mediated channel activity; when associated with Q-788. Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 788 | 1 | K → Q: Abolishes PLC-mediated channel activity; when associated with Q-785 or Q-797. Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 797 | 1 | R → Q: Abolishes PLC-mediated channel activity; when associated with Q-788. Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 800 | 1 | S → A: Largely reduces direct activation of by PMA and PMA-induced currents; no effect on receptor kinase-induced currents. Ref.9 Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 18 | 1 | E → D in BAA94307. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 36 | 1 | V → A in AAK83151. Ref.4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 48 | 1 | R → G in BAA94306. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 51 | 1 | G → W in BAA94306. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 96 | 1 | P → Q in BAA94307. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 179 | 1 | V → I in AAK83151. Ref.4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 735 | 1 | K → Q in BAA94306. Ref.3 | ||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 114 – 123 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 127 – 131 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 132 – 139 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 146 – 148 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 151 – 153 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 157 – 163 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 171 – 181 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 182 – 184 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 187 – 190 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 196 – 199 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 204 – 210 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 214 – 221 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 222 – 224 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 234 – 236 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 251 – 257 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 261 – 268 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 287 – 292 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 299 – 318 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 325 – 327 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 336 – 343 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 346 – 355 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 356 – 358 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| [1] | "The capsaicin receptor: a heat-activated ion channel in the pain pathway." Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. Nature 389:816-824(1997) [PubMed: 9349813] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY. Tissue: Spinal ganglion. |
| [2] | "Molecular cloning of an N-terminal splice variant of the capsaicin receptor. Loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes." Schumacher M.A., Moff I., Sudanagunta S.P., Levine J.D. J. Biol. Chem. 275:2756-2762(2000) [PubMed: 10644739] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, FUNCTION (ISOFORM 3). Strain: Sprague-Dawley. Tissue: Spinal ganglion and Trigeminal ganglion. |
| [3] | "Propofol activates vanilloid receptor channels expressed in human embryonic kidney 293 cells." Tsutsumi S., Tomioka A., Sudo M., Nakamura A., Shirakura K., Takagishi K., Kohama K. Neurosci. Lett. 312:45-49(2001) [PubMed: 11578842] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). |
| [4] | "The genomic organization of the gene encoding the vanilloid receptor: evidence for multiple splice variants." Xue Q., Yu Y., Trilk S.L., Jong B.E., Schumacher M.A. Genomics 76:14-20(2001) [PubMed: 11549313] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-468, ALTERNATIVE SPLICING. Strain: Sprague-Dawley. |
| [5] | "Identification of an aspartic residue in the P-loop of the vanilloid receptor that modulates pore properties." Garcia-Martinez C., Morenilla-Palao C., Planells-Cases R., Merino J.M., Ferrer-Montiel A.V. J. Biol. Chem. 275:32552-32558(2000) [PubMed: 10931826] [Abstract] Cited for: CHARACTERIZATION OF CHANNEL PORE, MUTAGENESIS OF GLU-636; LYS-639; MET-644; ASP-646; GLU-648 AND GLU-651. |
| [6] | "Induction of vanilloid receptor channel activity by protein kinase C." Premkumar L.S., Ahern G.P. Nature 408:985-990(2000) [PubMed: 11140687] [Abstract] Cited for: FUNCTION. |
| [7] | "Biochemical characterization of the vanilloid receptor 1 expressed in a dorsal root ganglia derived cell line." Jahnel R., Dreger M., Gillen C., Bender O., Kurreck J., Hucho F. Eur. J. Biochem. 268:5489-5496(2001) [PubMed: 11683872] [Abstract] Cited for: SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-604. |
| [8] | "Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition." Chuang H.H., Prescott E.D., Kong H., Shields S., Jordt S.E., Basbaum A.I., Chao M.V., Julius D. Nature 411:957-962(2001) [PubMed: 11418861] [Abstract] Cited for: FUNCTION, INTERACTION WITH PRKCG AND NTRK1. |
| [9] | "Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues." Numazaki M., Tominaga T., Toyooka H., Tominaga M. J. Biol. Chem. 277:13375-13378(2002) [PubMed: 11884385] [Abstract] Cited for: PHOSPHORYLATION AT SER-502 AND SER-800, MUTAGENESIS OF SER-502 AND SER-800. |
| [10] | "Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways." Olah Z., Karai L., Iadarola M.J. J. Biol. Chem. 277:35752-35759(2002) [PubMed: 12095983] [Abstract] Cited for: FUNCTION. |
| [11] | "cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation." Bhave G., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W. IV Neuron 35:721-731(2002) [PubMed: 12194871] [Abstract] Cited for: FUNCTION, PHOSPHORYLATION AT SER-116; THR-144; THR-370; SER-502; SER-774 AND SER-820. |
| [12] | "Structural determinant of TRPV1 desensitization interacts with calmodulin." Numazaki M., Tominaga T., Takeuchi K., Murayama N., Toyooka H., Tominaga M. Proc. Natl. Acad. Sci. U.S.A. 100:8002-8006(2003) [PubMed: 12808128] [Abstract] Cited for: FUNCTION, INTERACTION WITH CALMODULIN. |
| [13] | "Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1)." Bhave G., Hu H.J., Glauner K.S., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W. IV Proc. Natl. Acad. Sci. U.S.A. 100:12480-12485(2003) [PubMed: 14523239] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF SER-502; THR-704 AND SER-800. |
| [14] | "A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity." Prescott E.D., Julius D. Science 300:1284-1288(2003) [PubMed: 12764195] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ARG-785; LYS-788; ARG-797 AND SER-800. |
| [15] | "Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase." Jin X., Morsy N., Winston J., Pasricha P.J., Garrett K., Akbarali H.I. Am. J. Physiol. 287:C558-C563(2004) [PubMed: 15084474] [Abstract] Cited for: INTERACTION WITH CSK. |
| [16] | "Agonist recognition sites in the cytosolic tails of vanilloid receptor 1." Jung J., Lee S.Y., Hwang S.W., Cho H., Shin J., Kang Y.S., Kim S., Oh U. J. Biol. Chem. 277:44448-44454(2002) [PubMed: 12228246] [Abstract] Cited for: MUTAGENESIS OF ARG-114; ARG-115 AND GLU-761. |
| [17] | "Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding." Jung J., Shin J.S., Lee S.-Y., Hwang S.W., Koo J., Cho H., Oh U. J. Biol. Chem. 279:7048-7054(2004) [PubMed: 14630912] [Abstract] Cited for: FUNCTION, PHOSPHORYLATION AT SER-502 AND THR-704, MUTAGENESIS OF SER-502 AND THR-704. |
| [18] | "Molecular determinants of vanilloid sensitivity in TRPV1." Gavva N.R., Klionsky L., Qu Y., Shi L., Tamir R., Edenson S., Zhang T.J., Viswanadhan V.N., Toth A., Pearce L.V., Vanderah T.W., Porreca F., Blumberg P.M., Lile J., Sun Y., Wild K., Louis J.C., Treanor J.J. J. Biol. Chem. 279:20283-20295(2004) [PubMed: 14996838] [Abstract] Cited for: MUTAGENESIS OF TYR-511; MET-547 AND THR-550. |
| [19] | "TRPV1 acts as proton channel to induce acidification in nociceptive neurons." Hellwig N., Plant T.D., Janson W., Schafer M., Schultz G., Schaefer M. J. Biol. Chem. 279:34553-34561(2004) [PubMed: 15173182] [Abstract] Cited for: FUNCTION. |
| [20] | "Interaction between protein kinase Cmu and the vanilloid receptor type 1." Wang Y., Kedei N., Wang M., Wang Q.J., Huppler A.R., Toth A., Tran R., Blumberg P.M. J. Biol. Chem. 279:53674-53682(2004) [PubMed: 15471852] [Abstract] Cited for: INTERACTION WITH PRKCM, PHOSPHORYLATION AT SER-116, MUTAGENESIS OF SER-116. |
| [21] | "Identification of a tetramerization domain in the C-terminus of the vanilloid receptor." Garcia-Sanz N., Fernandez-Carvajal A., Morenilla-Palao C., Planells-Cases R., Fajardo-Sanchez E., Fernandez-Ballester G., Ferrer-Montiel A. J. Neurosci. 24:5307-5314(2004) [PubMed: 15190102] [Abstract] Cited for: SUBUNIT. |
| [22] | "Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain." Toth A., Boczan J., Kedei N., Lizanecz E., Bagi Z., Papp Z., Edes I., Csiba L., Blumberg P.M. Brain Res. Mol. Brain Res. 135:162-168(2005) [PubMed: 15857679] [Abstract] Cited for: TISSUE SPECIFICITY, SUBCELLULAR LOCATION. |
| [23] | "The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity." Lishko P.V., Procko E., Jin X., Phelps C.B., Gaudet R. Neuron 54:905-918(2007) [PubMed: 17582331] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 101-364, ATP-BINDING, DOMAINS ANKYRIN REPEATS. |
| [24] | "TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus." Chavez A.E., Chiu C.Q., Castillo P.E. Nat. Neurosci. 13:1511-1518(2010) [PubMed: 21076423] [Abstract] Cited for: FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF029310 mRNA. Translation: AAC53398.1. AF158248 mRNA. Translation: AAF28389.1. AB041029 mRNA. Translation: BAA94306.1. AB040873 mRNA. Translation: BAA94307.1. AF327067 Genomic DNA. Translation: AAK83151.1. AF327067 Genomic DNA. Translation: AAK83152.1. | ||||||||||||||||||
| IPI | IPI00326014. IPI00389268. IPI00561075. | ||||||||||||||||||
| PIR | T09054. | ||||||||||||||||||
| RefSeq | NP_114188.1. NM_031982.1. | ||||||||||||||||||
| UniGene | Rn.3073. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | O35433. | ||||||||||||||||||
| SMR | O35433. Positions 111-358. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | O35433. 1 interaction. | ||||||||||||||||||
| STRING | O35433. | ||||||||||||||||||
Protein family/group databases | |||||||||||||||||||
| TCDB | 1.A.4.2.1. transient receptor potential Ca2+ channel (TRP-CC) family. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | O35433. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PRIDE | O35433. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSRNOT00000026456; ENSRNOP00000026456; ENSRNOG00000019486. ENSRNOT00000026493; ENSRNOP00000026493; ENSRNOG00000019486. | ||||||||||||||||||
| GeneID | 83810. | ||||||||||||||||||
| KEGG | rno:83810. | ||||||||||||||||||
| UCSC | AF029310. rat. NM_031982. rat. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 7442. | ||||||||||||||||||
| RGD | 628841. Trpv1. | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | roNOG04377. | ||||||||||||||||||
| GeneTree | ENSGT00550000074425. | ||||||||||||||||||
| HOVERGEN | HBG054085. | ||||||||||||||||||
| InParanoid | O35433. | ||||||||||||||||||
| OrthoDB | EOG48WC1B. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | O35433. | ||||||||||||||||||
| Genevestigator | O35433. | ||||||||||||||||||
| GermOnline | ENSRNOG00000019486. Rattus norvegicus. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR002110. Ankyrin_rpt. IPR020683. Ankyrin_rpt-contain_dom. IPR005821. Ion_trans. IPR004729. TRP_channel. IPR008347. TRPV1-4_channel. IPR024862. TRPV_channel. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:1.25.40.20. ANK. 1 hit. | ||||||||||||||||||
| KO | K05222. | ||||||||||||||||||
| PANTHER | PTHR10582. PTHR10582. 1 hit. | ||||||||||||||||||
| Pfam | PF00023. Ank. 2 hits. PF00520. Ion_trans. 1 hit. [Graphical view] | ||||||||||||||||||
| PRINTS | PR01768. TRPVRECEPTOR. | ||||||||||||||||||
| SMART | SM00248. ANK. 4 hits. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF48403. ANK. 1 hit. | ||||||||||||||||||
| TIGRFAMs | TIGR00870. Trp. 1 hit. | ||||||||||||||||||
| PROSITE | PS50297. ANK_REP_REGION. 1 hit. PS50088. ANK_REPEAT. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| NextBio | 616421. | ||||||||||||||||||
Entry information
| Entry name | TRPV1_RAT | ||||||||
| Accession | Primary (citable) accession number: O35433 Secondary accession number(s): Q920B3 Q9JM57 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with